tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Abbisko Cayman Limited Schedules Board Meeting for Interim Results
PremiumCompany AnnouncementsAbbisko Cayman Limited Schedules Board Meeting for Interim Results
1M ago
Abbisko Therapeutics to Present Promising Phase 2 Study Results at ESMO GI Congress
Premium
Company Announcements
Abbisko Therapeutics to Present Promising Phase 2 Study Results at ESMO GI Congress
2M ago
Abbisko Therapeutics Advances Achondroplasia Study with First Patient Enrollment
Premium
Company Announcements
Abbisko Therapeutics Advances Achondroplasia Study with First Patient Enrollment
2M ago
Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for TGCT Treatment
PremiumCompany AnnouncementsAbbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for TGCT Treatment
3M ago
Abbisko Secures $85 Million from Merck for Pimicotinib Global Rights
Premium
Company Announcements
Abbisko Secures $85 Million from Merck for Pimicotinib Global Rights
3M ago
Abbisko Therapeutics’ Irpagratinib Receives Breakthrough Therapy Designation for HCC Treatment
Premium
Company Announcements
Abbisko Therapeutics’ Irpagratinib Receives Breakthrough Therapy Designation for HCC Treatment
3M ago
Abbisko’s CEO Increases Stake Amid Share Repurchase Plan
PremiumCompany AnnouncementsAbbisko’s CEO Increases Stake Amid Share Repurchase Plan
4M ago
Abbisko Therapeutics Unveils Promising Pre-Clinical Cancer Research at AACR 2025
Premium
Company Announcements
Abbisko Therapeutics Unveils Promising Pre-Clinical Cancer Research at AACR 2025
4M ago
Abbisko Cayman Limited Updates Post-IPO Schemes with Treasury Shares
Premium
Company Announcements
Abbisko Cayman Limited Updates Post-IPO Schemes with Treasury Shares
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100